CoChat

Clinical and functional significance of loss of caveolin‐1 expression in breast cancer‐associated fibroblasts

Simpkins, Samantha A, Hanby, Andrew M, Holliday, Deborah L, Speirs, Valerie · 2012 · The Journal of Pathology
Cited by 100

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Loss of caveolin‐1 (Cav‐1) expression in breast cancer‐associated fibroblasts (CAFs) is predictive of poor prognosis in breast cancer, but its function has not been established. Our study tested the hypotheses that loss of Cav‐1 expression in breast fibroblasts was associated with poor prognosis in breast cancer, through promotion of breast cancer cell invasion. Cav‐1 stromal expression was immunohistochemically assessed in 358 breast cancers. Cav‐1 expression in primary breast fibroblasts was analysed by western blot. Modified Boyden chamber assays determined fibroblast ability to promote invasion of breast cancer cells. The impact of siRNA silencing of Cav‐1 in fibroblasts was evaluated using invasion assays and 3D co‐culture assays. Loss of Cav‐1 expression in breast stroma was significantly associated with decreased breast cancer‐specific and disease‐free survival ( p = 0.01). Mean survival was 72 months (Cav‐1 + group) versus 29.5 months (Cav‐1 − group). This was confirmed in multivariate analysis. Cav‐1 expression was significantly decreased in CAFs compared to normal fibroblasts ( p = 0.01) and was associated with increased invasion‐promoting capacity. Cav‐1 siRNA‐treated fibroblasts promoted significantly increased invasion of MDA‐MB‐468 and T47D breast cancer cells from 27% (control) to 67% ( p = 0.006) and from 37% to 56%, respectively ( p = 0.01). 3D co‐cultures of MDA‐MB‐468 cells with myoepithelial cells led to the formation of organized cohesive structures when cultured with conditioned media from fibroblasts but resulted in a disorganized appearance in the presence of conditioned media from Cav‐1 siRNA‐treated fibroblasts, accompanied by loss of E‐cadherin expression in tumour cells. Our data confirm that loss of stromal Cav‐1 in breast cancer predicts poor outcome. At a functional level, Cav‐1‐deficient CAFs are capable of significantly increasing the invasive capacity of breast cancer cells. Copyright © 2012 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/path.4034

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 100

Metadata

Authors
Simpkins, S. A., Hanby, A. M., Holliday, D. L., & Speirs, V.
Venue
The Journal of Pathology
Publisher
Wiley
Published
2012-05-23
Volume
227
Issue
4
Pages
490-498
ISSN
  • 0022-3417 (ISSN-L)
  • 1096-9896
OpenAlex
W2011962069
Cited by
100
References
3
FWCI
4.83
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.